Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03608631
Title field or adapter rule
{'original_value': 'Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:26.537400+00:00
Published At
2026-09-04T00:00:00+00:00
Record Updated At
2026-09-04
Source Retrieved At
2026-10-31T22:17:58.991924+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["KRAS NP_004976.2:p.G12D", "Metastatic Pancreatic Adenocarcinoma", "Pancreatic Ductal Adenocarcinoma", "Stage IV Pancreatic Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-04", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT03608631"
protocolSection.identificationModule.officialTitle
"Phase I Study of Mesenchymal Stromal Cells-Derived Exosomes With KrasG12D siRNA for Metastatic Pancreas Cancer Patients Harboring KrasG12D Mutation"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • KRAS NP_004976.2:p.G12D (protocolSection.conditionsModule.conditions)
  • Metastatic Pancreatic Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Pancreatic Ductal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Stage IV Pancreatic Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['Treatment (iExosomes)'], 'description': 'Given IV', 'name': 'Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

  • Mesenchymal Stromal Cells-derived Exosomes with KRAS G12D siRNA (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.